Answer:
The answer is False. Although sensitive cells are <u>more abundant</u> in the <u>anterior portion</u> of the annelid´s body, in general, they are arranged in all the segments.
Explanation:
Annelids, such as the earthworm, have a variety of sensory cells:
- <u>Mechanoreceptors</u>, disposed of in groups in <em><u>each segment</u></em> of their body.
- <u>Photoreceptors</u>: Light-sensitive cells. Although they are <em><u>located in the whole </u></em>body, they are <em><u>abundant in anterior and posterior segments</u></em>, concentrated in the intern and dorsal part of the epidermis.
- <u>Humidity receptors</u> are the most sensitive cells and are <u>located in the first segments</u> of the earthworm body
- <u>Chemoreceptors</u>: sensorial cells cumulus forming a prominent tubercle with prolongations that extends through the cuticle. These tubercles form three rings <em><u>in each segment</u></em> but are especially <em><u>abundant in the anterior part</u></em> of the body.
The tegument is very rich in free nervous terminations, which functions might be tactile.
The answer is: "global" .
______________________________
Endoplasmic Recticulum:
<span>a network of membranous tubules within the cytoplasm of a eukaryotic cell, continuous with the nuclear membrane. It usually has ribosomes attached and is involved in protein and lipid synthesis</span>
Hello.
The answer is: C.nucleus.
It instructs and is known for cell growth and reproduction.
Answer:
Explanation:
The more similar the two species are, the more their niche overlaps and the more competition there is.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/</em>